Some positions in the index are not supported for direct indices on Frec due to fractional trade limitations from our clearing firm.
54 positions0.40% of market cap
Position ↓ |
|---|
![]() ABVXAbivax SA ADR |
![]() AKTXAkari Therapeutics Plc ADR |
![]() AMRNAmarin Corp Plc ADR |
![]() AMTDAMTD IDEA Group ADR |
![]() ARBKArgo Blockchain Plc ADR |
![]() ATHEAlterity Therapeutics Ltd ADR |
![]() BCYCBicycle Therapeutics Plc DR |
![]() BDRXBiodexa Pharmaceuticals plc ADR |
![]() BLRXBioline RX Ltd ADR |
![]() BRNSBarinthus Biotherapeutics plc ADR |
![]() BWAYBrainsway Ltd. ADR |
![]() CANFCan Fite Biopharma Ltd.ADR |
![]() CDLRCADELER A/S ADR |
![]() CMMBChemomab Therapeutics ADR |
![]() CNTACentessa Pharmaceuticals plc ADR |
![]() DBVTDBV Technologies SA |
![]() EDAPEdap TMS SA ADR |
![]() ELWSEarlyworks Co., Ltd. ADR |
![]() EVAXEvaxion A/S ADS |
![]() FRSXForesight Autonomous Holdings Ltd ADR |
![]() HCMHUTCHMED (China) Limited ADR |
![]() HDLSUPER HI INTERNATIONAL HOLDING LTD. ADR |
![]() HKDAMTD Digital Inc. ADR Class A |
![]() IMCRImmunocore Holdings Plc ADS |
![]() IPHAInnate Pharma ADR |
![]() IPXIperionX Limited-ADR |
![]() KZIAKazia Therapeutics Limited ADS |
![]() LGHLLion Group Holding Ltd |
![]() LUXELuxExperience B.V. ADR |
![]() MREOMereo BioPharma Group plc-ADR |
![]() MRMMEDIROM Healthcare Technologies, Inc.DR |
![]() NCNANuCana plc ADR |
![]() NVANova Minerals Limited ADR |
![]() NWGLNature Wood Group Limited ADR |
![]() OTLYOatly Group AB ADS |
![]() PCLAPicoCELA Inc. ADR |
![]() PPBTPURPLE BIOTECH LTD |
![]() PSNYPolestar Automotive Holding UK PLC |
![]() RADXRadiopharm Theranostics Ltd |
![]() RDHLRedHill Biopharma Ltd. ADS |
![]() SCNIScinai Immunotherapeutics Ltd. ADR |
![]() SLNSilence Therapeutics Plc ADR |
![]() SQNSSequans Communications SA |
![]() STKHSteakholder Foods Ltd.ADR |
![]() SVRESaverOne 2014 Ltd. ADR |
![]() TDTHTrident Digital Tech Holdings Ltd |
![]() TKLFTokyo Lifestyle Co., Ltd. ADR |
![]() TLXTelix Pharmaceuticals Ltd ADR |
![]() TRIBTrinity Biotech ADR |
![]() VEONVEON Ltd ADR |

















































